Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enolase 1 pseudogene 4 (ENO1P4) is one of several identified pseudogenes related to the enolase 1 (ENO1) gene. Pseudogenes are segments of DNA resembling functional genes but are non-coding, typically resulting from gene duplication or retrotransposition events. ENO1P4 does not produce a functional protein and has no direct biological activity or known utility as a therapeutic target. Its only relevance is in genomic annotation and bioinformatic analyses for distinguishing functional genes from non-coding homologs[1][3]. If you are looking for information on the functional enzyme "enolase 1" (alpha-enolase, ENO1), refer to that canonical gene/protein, which is a glycolytic enzyme and a potential cancer target[1][2][3]. But ENO1P4 as a pseudogene is not a drug target, does not encode a protein, and does not participate in any known biological or disease processes[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enolase 1 pseudogene 4 (ENO1P4).